MedPath

A systematic study on the syndrome differentiation standard of lingnan wet syndrome - ulcerative colitis

Phase 1
Conditions
lcerative colitis
Registration Number
ITMCTR2200006063
Lead Sponsor
Guangdong Provincial Hospital of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Meet the diagnostic criteria of UC in Western medicine;
(2) Aged between 18 and 75;
(3) Signed informed consent with good compliance and can be followed up;
(4) Normal cognitive function, no dyslexia, can actively cooperate with the investigation and research.

Exclusion Criteria

(1) Chronic schistosomiasis, bacterial dysentery, intestinal tuberculosis and other infectious colitis, colonic Crohn's disease, radiation enteritis, ischemic enteritis;
(2) Patients in lactation, pregnant women and intolerant to this drug;
(3) patients with serious primary diseases such as heart, lung, liver, kidney and hematopoietic system, and mental illness;
(4) Patients with serious complications such as local stenosis, toxic megacolon, intestinal obstruction, colon cancer, rectal cancer, intestinal perforation and anal diseases;
(5) persons with disabilities defined by law (mute, deaf, blind, mental disorder, physical disability, intellectual disability).

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease recurrence rate;
Secondary Outcome Measures
NameTimeMethod
erythrocyte sedimentation rate;Inflammatory Bowel Disease Quality of Life Questionnaire;TCM wet syndrome evaluation scale;c reactive protein;UC Disease activity index;Individual symptom efficacy;TCM syndrome effect;
© Copyright 2025. All Rights Reserved by MedPath